Ontology highlight
ABSTRACT: Introduction
Rare diseases (RD) are collectively common and often genetic. Families value and can benefit from precise molecular diagnoses. Prolonged diagnostic odysseys exacerbate the burden of RD on patients, families and the healthcare system. Genome sequencing (GS) is a near-comprehensive test for genetic RD, but existing care models-where consultation with a medical geneticist is a prerequisite for testing-predate GS and may limit access or delay diagnosis. Evidence is needed to guide the optimal positioning of GS in care pathways. While initiating GS prior to geneticist consultation has been trialled in acute care settings, there are no data to inform the utility of this approach in outpatient care, where most patients with RD seek genetics services. We aim to evaluate the di
SUBMITTER: Stanley KJ
PROVIDER: S-EPMC12336508 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature